This case-control study will evaluate a broad range of potential risk factors that may be involved in ovarian cancer etiology: reproductive, hormonal, nutritional, genetic, occupational, etc. Attempt will be made to assess the differential interaction of these factors in various disease subentities manifested by histologic, hormonal and other tumor characteristics. It will include about 400 incident cases of ovarian cancer occurring in Israel during two and half years, and 800 controls matched by age and ethnicity (400 surgical and 400 neighborhood). Emphasis will be made on the role of risk factors in high and low risk populations i.e. the two main ethnic groups of the Israeli Jews which differ in their life styles and relevant exposures. This gradient in incidence is similar to the one between white/black populations in the U.S. Thus, the results will be applicable to the U.S. community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA061126-01
Application #
3204608
Study Section
Special Emphasis Panel (SRC (52))
Project Start
1993-09-29
Project End
1996-08-31
Budget Start
1993-09-29
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Chaim Sheba Medical Center
Department
Type
DUNS #
City
Ramat Gan
State
Country
Israel
Zip Code
52621
Bolton, Kelly L; Chenevix-Trench, Georgia; Goh, Cindy et al. (2012) Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA 307:382-90
Chetrit, Angela; Hirsh-Yechezkel, Galit; Ben-David, Yehuda et al. (2008) Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer. J Clin Oncol 26:20-5
Lubin, Flora; Chetrit, Angela; Modan, Baruch et al. (2006) Dietary intake changes and their association with ovarian cancer risk. J Nutr 136:2362-7
Lubin, F; Chetrit, A; Freedman, L S et al. (2003) Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157:113-20
Hirsh-Yechezkel, G; Chetrit, A; Lubin, F et al. (2003) Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel. Gynecol Oncol 89:494-8
Rutter, Joni L; Wacholder, Sholom; Chetrit, Angela et al. (2003) Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst 95:1072-8
Ben David, Y; Chetrit, A; Hirsh-Yechezkel, G et al. (2002) Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 20:463-6
Modan, B; Hartge, P; Hirsh-Yechezkel, G et al. (2001) Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med 345:235-40
Modan, B (1998) The genetic passport. Am J Epidemiol 147:513-5
Modan, B; Gak, E; Sade-Bruchim, R B et al. (1996) High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer. JAMA 276:1823-5